Why the study?
Severe symptoms often occur without measurable pathology in post-COVID syndrome, prompting investigation into whether induced breathlessness during a CO2 rebreathing challenge reflects altered respiratory measures.
Does a controlled CO2 rebreathing challenge reveal differences in breathlessness perception or respiratory physiology in patients with post-COVID syndrome compared to healthy controls?
Does a controlled CO2 rebreathing challenge reveal differences in breathlessness perception or respiratory physiology in patients with post-COVID syndrome compared to healthy controls?
Patients with post-COVID syndrome experience increased breathlessness perception despite intact breathing patterns and physiology, suggesting altered internal sensory models.
Suggests altered breathlessness perception in post-COVID despite normal physiology; hypothesis-generating for sensory mechanisms and interventions.
Severe symptoms in the absence of measurable body pathology are a frequent hallmark of post-COVID syndrome. From a Bayesian Brain perspective, such symptoms can be explained by incorrect internal models that the brain uses to interpret sensory signals. In this pre-registered study, we investigate whether induced breathlessness perception during a controlled CO 2 rebreathing challenge is reflected by altered respiratory measures (physiology and breathing patterns), and propose different computational mechanisms that could explain our findings in a Bayesian Brain framework. We analysed data from 40 patients with post-COVID syndrome and 40 healthy participants. Results from lung function, neurological and neurocognitive examination of all participants were within normal limits on the day of the experiment. Using a Bayesian repeated-measures ANOVA, we found that patients’ breathlessness was strongly increased (BF 10, baseline =8.029, BF 10, rebreathing =11636, BF 10, recovery =43662) compared to controls. When excluding patients who hyperventilated ( N = 8, 20%) during the experiment from the analysis, differences in breathlessness remained (BF 10, baseline =1.283, BF 10, rebreathing =126.812, BF 10, recovery =751.282). For physiology and breathing patterns, all evidence pointed towards no difference between the two groups (0.307 > BF 10 < 0.704). In summary, we found intact breathing patterns and physiology but increased symptom perception in patients with post-COVID syndrome.
No takes yet. Share an insight, caveat, or question.
Werder et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: